Product # |
Name |
|
9CI — see Ridaforolimus, Cat. No. R-7040. |
A-1803 |
A-769662, >99% |
A-6880 |
17-AAG, >99% |
|
AB-1010 — see Masitinib, Free Base, Cat. No. M-7007. |
|
ABT-578 — see Zotarolimus, Cat. No. Z-9040. |
|
AC010220 — see Quizartinib, Free Base, Cat. No. Q-4747 . |
|
AC220 — see Quizartinib, Free Base, Cat. No. Q-4747 . |
A-6900 |
6"-O-Acetyldaidzin, >98% |
|
Acetyldinaline — see CI-994, Free Base, Cat. No. C-2606. |
A-3000 |
6"-O-Acetylgenistin, >98% |
A-7860 |
6"-O-Acetylglycitin, >98% |
|
Adeo — see (R,S)-Rolipram, Cat. No. R-2020. |
|
Adriacin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
|
Adriamycin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
|
Adriblastin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
|
Adriblastina — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
A-8644 |
Afatinib, Free Base, >99% |
|
Afinitor — see its active ingredient, namely Everolimus, Cat. No. E-4040. |
|
AG 490 — see Tyrphostin AG 490, Cat. No. T-9142. |
|
AG 1478 — see Tyrphostin AG 1478, Cat. No. T-7310. |
|
AG-013736 — see Axitinib, Free Base, Cat. No. A-1107. |
|
Alimta — see its active ingredient, namely Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177. |
|
17-(Allylamino)-17-Demethoxygeldanamycin — see 17-AAG, Cat. No. A-6880. |
|
17-(Allylamino)geldanamycin — see 17-AAG, Cat. No. A-6880. |
|
Alvespimycin — see 17-DMAG, Cat. No. D-3440. |
|
AMG-706 — see Motesanib, Diphosphate Salt, Cat. No. M-2999 and Motesanib, Free Base, Cat. No. M-2900. |
|
2'-Amino-3'-methoxyflavone — see PD 98059, Cat. No. P-4313. |
|
AMN-107 — see Nilotinib, Cat. No. N-8207. |
|
3-Angeloyl Ingenol — see Ingenol 3-Angelate, Cat. No. I-5900. |
|
3-Angelyl Ingenol — see Ingenol 3-Angelate, Cat. No. I-5900. |
|
Anthra(1,9-cd)pyrazol-6(2H)-one — see SP600125, Cat. No. S-7979. |
|
Anthrapyrazolone — see SP600125, Cat. No. S-7979. |
|
Antibiotic AM-2282
— see Staurosporine, Cat. No. S-9300. |
|
Antibioitic S 7481F1 — see Cyclosporin A, Cat. No. C-6000. |
|
ANX-530 — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. |
|
AP 23573 — see Ridaforolimus, Cat. No. R-7040. |
|
Armala — see Pazopanib, Free Base, Cat. No. P-6706. |
|
ARRY-142886 — see Selumetinib, Free Base, Cat. No. S-4490. |
|
ARRY-886 — see Selumetinib, Free Base, Cat. No. S-4490. |
A-1040 |
Ascomycin, >99% |
|
Ascotoxin — see Brefeldin A, Cat. No. B-8500.
|
|
AT-877 — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt, Cat. No. H-2330. |
|
ATS 1287B — see Leptomycin B, Free Acid, Cat. No. L-6100.
|
|
AUY922 — see NVP-AUY922, Free Base, Cat. No. N-5300.
|
|
AV-951 — see Tivozanib, Free Base, Cat. No. T-6466.
|
A-1107 |
Axitinib, Free Base, >99% |
|
AY-22989 — see Rapamycin, Cat. No. R-5000.
|
|
AZD-0530 — see Saracatinib, Free Base, Cat. No. S-8906. |
|
AZD2171 — see Cediranib, Free Base, Cat. No. C-4300 . |
|
AZD-2281 — see Olaparib, Cat. No. O-9201. |
|
AZD6244 — see Selumetinib, Free Base, Cat. No. S-4490. |
|
B705008K112 — see Bryostatin 1, Cat. No. B-6697.
|
|
Baccatin III N-benzyl-β-phenylisoserine ester — see Paclitaxel, Cat. No. P-9600.
|
B-1080 |
BafilomycinA1, >95% |
|
Bay 43-9006 — see Sorafenib, p-Toluenesulfonate Salt, Cat. No. S-8502 and Sorafenib, Free Base, Cat. No. S-8599. |
|
N-Benzoyl-7-oxostaurosporine — see Stauprimide, Cat. No. S-9344. |
|
4'-N-Benzoyl Staurosporine — see PKC412, Cat. No. P-7600. |
B-2422 |
Bexarotene, Free Acid, >99% |
|
BEZ235 — see NVP-BEZ235, Free Base, Cat. No. N-4288. |
|
BFA — see Brefeldin A, Cat. No. B-8500. |
|
BIBF1120 — see Vargatef, Free Base, Cat. No. V-9077. |
|
BIBW-2992 — see BIIB021, Free Base, Cat. No. B-7100. |
B-7100 |
BIIB021, Free Base, >99% |
|
Biovelbin — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. |
|
BIRB 796 — see Doramapimod, Free Base, Cat. No. D-2744. |
|
BMS-354825 — see Dasatinib, Free Base, Cat. No. D-3307. |
|
BMY-40481 — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
B-1408 |
Bortezomib, Free Base, >99% |
B-1709 |
Bosutinib, Free Base, >99% |
B-8500 |
Brefeldin A, >99% |
B-6697 |
Bryostatin 1, >99% |
B-3517 |
Bryostatin 2, >99% |
|
BSI-201 — see Iniparib, Cat. No. I-5432. |
|
Caelyx — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
C-3987 |
Calyculin A, >98% |
|
Campto — see its active ingredient, namely Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. |
|
Camptosar — see its active ingredient, namely Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. |
|
Camptothecin 11 — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. |
C-1201 |
Canertinib, Dihydrochloride Salt, >99% |
|
Capecitabin — see Capecitabine, Cat. No. C-2799. |
C-2799 |
Capecitabine, >99% |
|
Capecitibine — see Capecitabine, Cat. No. C-2799. |
|
Capecytabine — see Capecitabine, Cat. No. C-2799. |
|
Capiibine — see Capecitabine, Cat. No. C-2799. |
|
Caprelsa — see Vandetanib, Cat. No. V-9402. |
|
Captabin — see Capecitabine, Cat. No. C-2799. |
|
Caxeta — see Capecitabine, Cat. No. C-2799. |
|
CCI-779 — see Temsirolimus, Cat. No. T-8040. |
C-1502 |
Cediranib, Free Base, >99% |
|
Celebra — see its active ingredient, namely Celecoxib, Cat. No. C-1502. |
|
Celebrex — see its active ingredient, namely Celecoxib, Cat. No. C-1502. |
|
Celecox — see Celecoxib, Cat. No. C-1502. |
C-1502 |
Celecoxib, >99% |
|
CEP-701 — see Lestaurtinib, Cat. No. L-6307. |
|
Certican — see its active ingredient, namely Everolimus, Cat. No. E-4040. |
|
cFMS Receptor Tyrosine Kinase Inhibitor — see GW2580, Free Base, Cat. No. G-5903. |
|
CGP41251 — see PKC412, Cat. No. P-7600.
|
|
CGP-57148B — see Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508.
|
|
CGP-79787 — see Vatalanib, Free Base, Cat. No. V-8355 and Vatalanib, Dihydrochloride Salt, Cat. No. V-8303.
|
C-3030 |
Chelerythrine Chloride, >99% |
|
CHIR-258 — see Dovitinib, Free Base, Cat. No. D-3608 and Dovitinib, Lactate Salt, Cat. No. D-3699. |
|
CHIR 911 — see CHIR99021, Free Base, Cat. No. C-6556.
|
C-6556 |
CHIR99021, Free Base, >99% |
|
CI-940 — see Leptomycin B, Free Acid, Cat. No. L-6100. |
C-2606 |
CI-994, Free Base, >99% |
|
CI-1033 — see Canertinib, Dihydrochloride Salt, Cat. No. C-1201. |
|
CI-1040 — see PD 184352, Free Base, Cat. No. P-8499. |
|
Ciclosporin A — see Cyclosporin A, Cat. No. C-6000. |
|
CL-1957A — see Leptomycin B, Free Acid, Cat. No. L-6100. |
|
CNF-101 — see 17-AAG, Cat. No. A-6880. |
|
CNF2024 — see BIIB021, Free Base, Cat. No. B-7100. |
|
Cocarcinogen A1 — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680. |
|
Colforsin — see Forskolin, Cat. No. F-9929. |
|
CP 127374 — see 17-AAG, Cat. No. A-6880. |
|
CP-358774 — see Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007. |
|
CP-690550 — see Tofacitinib, Free Base, Cat. No. T-1377. |
|
CPT-11 — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. |
C-7900 |
Crizotinib, Free Base, >99% |
|
CsA — see Cyclosporin A, Cat. No. C-6000.
|
|
CSF-1 Receptor Inhibitor — see GW2580, Free Base, Cat. No. G-5903. |
|
CT53518 — see Tandutinib, Free Base, Cat. No. T-7802. |
|
CT99021 — see CHIR99021, Free Base, Cat. No. C-6556. |
C-8460 |
CUDC-101, Free Base, >99% |
|
Cyanein — see Brefeldin A, Cat. No. B-8500.
|
|
CYC202 — see Roscovitine, Cat. No. R-1234.
|
C-8700 |
Cyclopamine, Free Base, 99% |
C-6000 |
Cyclosporin A, >99% |
|
Cyclosporine — see Cyclosporin A, Cat. No. C-6000.
|
|
D04014 — see Enzastaurin, Free Base, Cat. No. E-4506. |
|
Dacplat — see Oxaliplatin, Cat. No. O-7111. |
D-2946 |
Daidzein, >99% |
D-7878 |
Daidzin, >99% |
D-3307 |
Dasatinib, Free Base, >99% |
|
Decumbin — see Brefeldin A, Cat. No. B-8500. |
|
Deforolimus — see Ridaforolimus, Cat. No. R-7040. |
|
11-Deoxyjervine — see Cyclopamine, Free Base, Cat. No. C-8700. |
|
12-Deoxyphorbol 13-Acetate — see Prostratin, Cat. No. P-4462. |
|
dFdC — see Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. |
|
dFdCyd — see Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. |
D-9200 |
(R,S)-2,3-Dihydrodaidzein, >99% |
|
4',7-Dihydroxyisoflavone — see Daidzein, Cat. No. D-2946. |
|
4',7-Dihydroxyisoflavone, 7-O-β-D-glucopyranoside — see Daidzin, Cat. No. D-7878. |
|
4',7-Dihydroxy-6-methoxyisoflavone — see Glycitein, Cat. No. G-1152. |
|
17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin — see 17-DMAG, Hydrochloride Salt, Cat. No. D-3440. |
|
DJM-166 — see PX-866, Cat. No. P-7501. |
|
DJM-2-166 — see PX-866, Cat. No. P-7501. |
D-3440 |
17-DMAG, Hydrochloride Salt, >99% |
D-1000 |
Docetaxel, >99% |
D-2744 |
Doramapimod, Free Base, >99% |
D-3608 |
Dovitinib, Free Base, >99% |
D-3699 |
Dovitinib, Lactate Salt, >99% |
|
Dox — see Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
|
Doxil — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
D-4099 |
Doxorubicin, Free Base, >99% |
D-4000 |
Doxorubicin, Hydrochloride Salt, >99% |
|
dPAc — see Prostratin, Cat. No. P-4462. |
|
DQ-2805 — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. |
|
Elactocin — see Leptomycin B, Free Acid, Cat. No. L-6100. |
|
Elidel — see its active ingredient, namely Pimecrolimus, Cat. No. P-6040. |
|
Ellence — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000. |
|
Eloxatin — see its active ingredient, namely Oxaliplatin, Cat. No. O-7111. |
|
Eloxatine — see Oxaliplatin, Cat. No. O-7111. |
|
Elplat — see Oxaliplatin, Cat. No. O-7111. |
E-3866 |
Entinostat, Free Base, >99% |
E-4506 |
Enzastaurin, Free Base, >99% |
|
Epiadriamycin — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000. |
|
4'-Epidoxorubicin — see Epirubicin, Hydrochloride Salt, Cat. No. E-8000. |
|
Epirubicin Ebewe — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000. |
E-8000 |
Epirubicin, Hydrochloride Salt, >99% |
|
EPO-906 — see Epothilone B, Free Base, Cat. No. E-5500. |
|
EpoB — see Epothilone B, Free Base, Cat. No. E-5500. |
|
Eposin — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
E-5500 |
Epothilone B, Free Base, >99% |
E-5880 |
(R,S)-Equol, >99% |
|
Eril — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt, Cat. No. H-2330. |
E-4997 |
Erlotinib, Free Base, >99% |
E-4007 |
Erlotinib, Hydrochloride Salt, >99% |
|
Etophos — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
|
Etopofos — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
|
Etopophos — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
E-4488 |
Etoposide, >99% |
|
Etoposide 4'-Dihydrogenphosphate — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
E-4444 |
Etoposide 4'-Phosphate, Free Acid, >99% |
|
Eunades — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. |
E-4040 |
Everolimus, >99% |
|
Evotropin — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622. |
|
Exelbine — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. |
|
Faridak — see Panobinostat, Free Base, Cat. No. P-3703. |
|
Farmiblastina — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
|
Fasudil — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt, Cat. No. H-2330. |
F-4660 |
Fasudil, Monohydrochloride Salt, >99% |
|
FHPI — see SB 202190, Free Base, Cat. No. S-1700. |
|
FI-106 — see Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
F-4633 |
Fingolimod, Hydrochloride Salt, >99% |
F-4900 |
FK-506, >99% |
|
FK-520 — see Ascomycin, Cat. No. A-1040. |
|
Foloxatine — see Oxaliplatin, Cat. No. O-7111. |
F-9929 |
Forskolin, >99% |
|
FR 900520 — see Ascomycin, Cat. No. A-1040. |
|
FTY720 — see Fingolimod, Hydrochloride Salt, Cat. No. F-4633. |
|
FTY-720A — see Fingolimod, Hydrochloride Salt, Cat. No. F-4633. |
|
Fujimycin — see FK-506, Cat. No. F-4900. |
|
Gamcitabine — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. |
|
GDC-0449 — see Vismodegib, Free Base, Cat. No. V-4050. |
G-9252 |
GDC-0941, Free Base, >99% |
G-4408 |
Gefitinib, Free Base, >99% |
G-4500 |
Geldanamycin, >99% |
|
Geldanomycin — see Geldanamycin, Cat. No. G-4500. |
G-4199 |
Gemcitabine, Free Base, >99% |
G-4177 |
Gemcitabine, Hydrochloride Salt, >99% |
|
Gemcitera — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. |
|
Gemsar — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. |
|
Gemzar — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. |
G-6055 |
Genistein, >99% |
G-5200 |
Genistin, >99% |
|
GLD-36 — see 17-AAG, Cat. No. A-6880. |
|
Glamox — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508. |
|
Gleevec — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508. |
|
Glivec — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508. |
G-1152 |
Glycitein, >99% |
G-2822 |
Glycitin, >99% |
|
Goe 5549 — see CI-994, Free Base, Cat. No. C-2606. |
|
Gö 5549 — see CI-994, Free Base, Cat. No. C-2606. |
G-6203 |
Gö 6976, >99% |
|
GSK-3 Inhibitor XVI — see CHIR99021, Free Base, Cat. No. C-6556. |
|
GSK 572016 — see Lapatinib, Free Base, Cat. No. L-4899. |
G-5903 |
GW2580, Free Base, >99% |
|
GW-572016 — see Lapatinib, Free Base, Cat. No. L-4899 and Lapatinib, Di-p-Toluenesulfonate Salt, Cat. No. L-4804. |
|
GW 572016X — see Lapatinib, Free Base, Cat. No. L-4899. |
|
GW-786034 — see Pazopanib, Free Base, Cat. No. P-6706. |
H-5239 |
H-89, Dihydrochloride Salt, >99% |
|
HA-1077 — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt. |
H-2330 |
HA-1077, Dihydrochloride Salt, >99% |
|
Halochondrine A — see Okadaic Acid, Free Acid, Cat. No. O-2220. |
|
Halochondrine A, Ammonium Salt — see Okadaic Acid, Ammonium Salt, Cat. No. O-6410. |
|
Halochondrine A, Potassium Salt — see Okadaic Acid, Potassium Salt, Cat. No. O-7519. |
|
Halochondrine A, Sodium Salt — see Okadaic Acid, Sodium Salt, Cat. No. O-5857. |
|
HhAntag691 — see Vismodegib, Free Base, Cat. No. V-4050. |
|
Histone Deacetylase Inhibitor I — see Entinostat, Free Base, Cat. No. E-3866. |
|
HKI-272 — see Neratinib, Free Base, Cat. No. N-6404. |
|
Hycamptamine — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622. |
|
Hycamtin — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622. |
|
14-Hydroxydaunomycin — see Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
|
14-Hydroxydaunorubicine — see Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
I-5577 |
Imatinib, Free Base, >99% |
|
Imatinib Mesylate — see Imatinib, Methanesulfonate Salt, Cat. No. I-5508. |
I-5508 |
Imatinib, Methanesulfonate Salt, >99% |
|
Immunomycin — see Ascomycin, Cat. No. A-1040. |
|
INCB018424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688. |
|
INCB18424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688. |
|
IND-71677 — see Iniparib, Cat. No. I-5432. |
I-1711 |
(-)-Indolactam V, >99% |
I-8560 |
Ingenol, >99% |
I-5900 |
Ingenol 3-Angelate, >99% |
|
3-Ingenyl Angelate — see Ingenol 3-Angelate, Cat. No. I-5900. |
|
Ingenyl 3-Angelate — see Ingenol 3-Angelate, Cat. No. I-5900. |
I-5432 |
Iniparib, 99% |
|
Intedanib — see Vargatef, Cat. No. V-9077. |
|
4-Iodo-3-nitrobenzamide — see Iniparib, Cat. No. I-5432. |
I-6800 |
Ionomycin, Calcium Salt, >99% |
I-5700 |
Ionomycin, Free Acid, >99% |
|
Iressa — see its active ingredient, namely Gefitinib, Free Base, Cat. No. G-4408. |
I-4122 |
Irinotecan, Hydrochloride Salt, Trihydrate, >99% |
|
4',7-Isoflavandiol — see Equol, Cat. No. E-5880. |
|
Jakafi — see its active ingredient, namely Ruxolitinib, Free Base, Cat. No. D-4099 and Ruxolitinib, Phosphate Salt, Cat. No. D-4000. |
|
JNK Inhibitor II — see SP600125, Cat. No. S-7979. |
K-2151 |
K252a, >99% |
K-9609 |
K252c, >99% |
|
K-252a — see K252a, Cat. No. K-2151. |
|
K-252c — see K252c, Cat. No. K-9609. |
|
KOS-953 — see 17-AAG, Cat. No. A-6880. |
|
KRN-951 — see Tivozanib, Free Base, Cat. No. T-6466. |
|
KRX-0401 — see Perifosine, Cat. No. P-6522. |
|
KT-5555 — see Lestaurtinib, Cat. No. L-6307. |
K-9090 |
KU-0063794, Free Base, >99% |
|
KU-59436 — see Olaparib, Cat. No. O-9201. |
|
KU-63794 — see KU-0063794, Free Base, Cat. No. K-9090. |
|
KW-2307 — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. |
|
KY 12420 — see Wortmannin, Cat. No. W-2990. |
|
L 683590 — see Ascomycin, Cat. No. A-1040. |
L-4804 |
Lapatinib, Di-p-Toluenesulfonate Salt, >99% |
L-4899 |
Lapatinib, Free Base, >99% |
|
Lastet — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
|
LBH-589 — see Panobinostat, Free Base, Cat. No. P-3703. |
|
LCP-Siro — see Rapamycin, Cat. No. R-5000. |
L-6100 |
Leptomycin B, Free Acid, >99% |
L-6307 |
Lestaurtinib, >99% |
|
LG 1069 — see Bexarotene, Free Acid, Cat. No. B-2422. |
|
LG100069 — see Bexarotene, Free Acid, Cat. No. B-2422. |
|
LGD-1069 — see Bexarotene, Free Acid, Cat. No. B-2422. |
|
Lipodox — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
|
LMB — see Leptomycin B, Free Acid, Cat. No. L-6100. |
|
LY-188011 — see Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. |
|
LY-231514 — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177. |
L-7962 |
LY 294002, >99% |
|
LY-317615 — see Enzastaurin, Free Base, Cat. No. E-4506. |
M-6730 |
6"-O-Malonyldaidzin, Free Acid, >98% |
M-8090 |
6"-O-Malonylgenistin, Free Acid, >98% |
M-4620 |
6"-O-Malonylglycitin, Free Acid, >98% |
|
Mantuamycin — see Leptomycin B, Free Acid, Cat. No. L-6100. |
|
Masatinib — see Masitinib, Free Base, Cat. No. M-7007. |
M-7007 |
Masitinib, Free Base, >99% |
|
ME-3167 — see (R,S)-Rolipram, Cat. No. R-2020. |
|
MEK1/2 Inhibitor III — see PD 325901, Free Base, Cat. No. P-9688. |
|
MG-0103 — see Mocetinostat, Free Base, Cat. No. M-2433. |
|
MG-341 — see Bortezomib, Free Base, Cat. No. B-1408. |
|
MGCD0103 — see Mocetinostat, Free Base, Cat. No. M-2433. |
|
Midostaurin — see PKC412, Cat. No. P-7600. |
|
MK-0683 — see Vorinostat, Cat. No. V-8477. |
|
MK-8669 — see Ridaforolimus, Cat. No. R-7040. |
|
MK-0457 — see Tozasertib, Free Base, Cat. No. T-2304. |
|
MLN518 — see Tandutinib, Free Base, Cat. No. T-7802. |
M-2433 |
Mocetinostat, Free Base, >99% |
M-2999 |
Motesanib, Diphosphate Salt, >99% |
M-2900 |
Motesanib, Free Base, 99% |
|
MS-27-275 — see Entinostat, Free Base, Cat. No. E-3866. |
|
MS-275 — see Entinostat, Free Base, Cat. No. E-3866. |
|
MS 275-27 — see Entinostat, Free Base, Cat. No. E-3866. |
|
MTA — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177. |
M-5602 |
Mubritinib, Free Base, >99% |
|
Myocet — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
|
Navelbine — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. |
|
NCB018424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688. |
|
NCB18424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688. |
|
Nectrolide — see Brefeldin A, Cat. No. B-8500. |
N-6404 |
Neratinib, Free Base, >99% |
|
Nexavar — see its active ingredient, namely Sorafenib, p-Toluenesulfonate Salt, Cat. No. S-8502 and Sorafenib, Free Base, Cat. No. S-8599. |
N-8207 |
Nilotinib, Free Base, >99% |
|
Nintedanib — see Vargatef, Cat. No. V-9077. |
|
NKA17 — see Perifosine, Cat. No. P-6522. |
|
Nogitecan — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622 . |
|
5'-Noranhydrovinblastine — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. |
|
Novaplus — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
|
NVB — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. |
N-5300 |
NVP-AUY922, Free Base, >99% |
N-4288 |
NVP-BEZ235, Free Base, >99% |
|
NVP-LBH-589 — see Panobinostat, Free Base, Cat. No. P-3703. |
O-1666 |
ODQ, Free Base, >98% |
O-6410 |
Okadaic Acid, Ammonium Salt, >98% |
O-2220 |
Okadaic Acid, Free Acid, >98% |
O-7519 |
Okadaic Acid, Potassium Salt, >98% |
O-5857 |
Okadaic Acid, Sodium Salt, >98% |
O-9201 |
Olaparib, >99% |
|
Onsenal — see Celecoxib, Cat. No. C-1502. |
|
OSI-774 — see Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007. |
O-5679 |
OSU-03012, Hydrochloride Salt, >99% |
|
OSU03012 — see OSU-03012, Hydrochloride Salt, Cat. No. O-5679. |
|
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one — see ODQ, Free Base, Cat. No. O-1666. |
|
Oxalato(1R,2R-cyclohexanediamine)platinum(II) — see Oxaliplatin, Cat. No. O-7111. |
|
Oxalatoplatin — see Oxaliplatin, Cat. No. O-7111. |
|
Oxalatoplatinum — see Oxaliplatin, Cat. No. O-7111. |
O-7111 |
Oxaliplatin, >99% |
P-9600 |
Paclitaxel, >99.5% |
P-3703 |
Panobinostat, Free Base, >99% |
|
Patupilone — see Epothilone B, Free Base, Cat. No. E-5500. |
P-6706 |
Pazopanib, Free Base, >99% |
P-4313 |
PD 98059, >99% |
|
PD 114720 — see Leptomycin B, Free Acid, Cat. No. L-6100. |
|
PD 123654 — see CI-994, Free Base, Cat. No. C-2606. |
P-3333 |
PD 173074, Free Base, >99% |
|
PD 183805 — see Canertinib, Dihydrochloride Salt, Cat. No. C-1201. |
P-8499 |
PD 184352, Free Base, >99% |
P-9688 |
PD 325901, Free Base, >99% |
|
PD0325901 — see PD 325901, Free Base, Cat. No. P-9688. |
|
PD 406976 — see Gö 6976, Cat. No. G-6203. |
|
PDBu — see Phorbol 12,13-Dibutyrate, Cat. No. P-4833. |
|
4α-PDD — see 4α-Phorbol 12,13-Didecanoate, Cat. No. P-2170. |
P-7177 |
Pemetrexed, Disodium Salt, Heptahydrate, >99% |
|
PEP005 — see Ingenol 3-Angelate, Cat. No. I-5900. |
P-6522 |
Perifosine, >99% |
|
PF-02341066 — see Crizotinib, Free Base, Cat. No. C-7900. |
|
PF-1066 — see Crizotinib, Free Base, Cat. No. C-7900. |
|
PF-02341066 — see Crizotinib, Free Base, Cat. No. C-7900. |
|
PHA-290940AD — see Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877. |
|
Pharmorubicin — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000. |
P-1010 |
Phorbol, >99% |
P-4833 |
Phorbol 12,13-Dibutyrate, >99% |
P-2170 |
4α-Phorbol 12,13-Didecanoate, >99% |
P-1680 |
Phorbol 12-Myristate 13-Acetate, >99.5% |
P-8880 |
4α-Phorbol 12-Myristate 13-Acetate, >99% |
|
PI3-Kinase α Inhibitor VIII — see PIK-75, Free Base, Cat. No. P-7858 and PIK-75, Hydrochloride Salt, Cat. No. P-7050. |
P-7858 |
PIK-75, Free Base, >98% |
P-7050 |
PIK-75, Hydrochloride Salt, >98% |
P-9050 |
PIK-90, Free Base, >98% |
P-6040 |
Pimecrolimus, >99% |
P-7600 |
PKC412, >99% |
|
PLX4032 — see Vemurafenib, Free Base, Cat. No. V-2800. |
|
PMA — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680. |
|
4α-PMA — see 4α-Phorbol 12-Myristate 13-Acetate, Cat. No. P-8880. |
|
PNU-290940AD — see Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877. |
P-6666 |
PP242, Free Base, >99% |
|
Prograf — see FK-506, Cat. No. F-4900. |
P-4462 |
Prostratin, >99% |
|
PS-341 — see Bortezomib, Free Base, Cat. No. B-1408. |
|
PTK 787 — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355. |
|
PTK/ZK — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355. |
P-7501 |
PX-866, >99% |
|
Pynasunate — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355. |
|
1,9-Pyrazoloanthrone — see SP600125, Cat. No. S-7979. |
Q-4747 |
Quizartinib, Free Base, >99% |
|
R-115777 — see Tipifarnib, Free Base, Cat. No. T-9104. |
|
R7204 — see Vemurafenib, Free Base, Cat. No. V-2800. |
|
RAD001 — see Everolimus, Cat. No. E-4040. |
|
Ramihyphin A — see Cyclosporin A, Cat. No. C-6000. |
|
RAPA — see Rapamycin, Cat. No. R-5000. |
|
Rapamune — see Rapamycin, Cat. No. R-5000. |
R-5000 |
Rapamycin, >99% |
|
Recentin — see its active ingredient, namely Cediranib, Free Base, Cat. No. C-4300. |
R-6712 |
Resiniferatoxin, >99% |
R-8765 |
Resiniferonol 9,13,14-Orthophenylacetate, >99% |
|
RG7204 — see Vemurafenib, Free Base, Cat. No. V-2800. |
R-7040 |
Ridaforolimus, >99% |
|
Ridorubicin — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000. |
|
ROPA — see Resiniferonol 9,13,14-Orthophenylacetate, Cat. No. R-8765. |
|
Ro 09-1978 — see Capecitabine, Cat. No. C-2799. |
|
Ro 50-8231 — see Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007. |
|
RO5185426 — see Vemurafenib, Free Base, Cat. No. V-2800. |
|
Rolazar — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177. |
R-2020 |
(R,S)-Rolipram, >99% |
R-1234 |
Roscovitine, Free Base, >99% |
R-9630 |
Rottlerin |
|
RP 54780— see Oxaliplatin, Cat. No. O-7111. |
|
RP 56976— see Docetaxel, Cat. No. D-1000. |
|
RTX — see Resiniferatoxin, Cat. No. R-6712. |
|
Rubex — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. |
R-6600 |
Ruxolitinib, Free Base |
R-6688 |
Ruxolitinib, Phosphate Salt |
|
SAHA — see Vorinostat, Cat. No. V-8477. |
|
SAPK Inhibitor II — see SP600125, Cat. No. S-7979. |
S-8906 |
Saracatinib, Free Base, >99% |
S-1700 |
SB 202190, Free Base, >99% |
S-3400 |
SB 203580, Free Base, >99% |
S-5100 |
SB 225002, >99% |
|
SB 95952 — see (R,S)-Rolipram, Cat. No. R-2020. |
|
SC-58635 — see Celecoxib, Cat. No. C-1502. |
|
SDP-012 — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. |
|
SDZ-ASM-981 — see Pimecrolimus, Cat. No. P-6040. |
|
SDZ-RAD — see Everolimus, Cat. No. E-4040. |
|
Seliciclib — see Roscovitine, Free Base, Cat. No. R-1234. |
S-4490 |
Selumetinib, Free Base, 98% |
S-7272 |
Sepantronium Bromide, 98% |
|
SILA 9268A — see Rapamycin, Cat. No. R-5000. |
|
Sirolimus — see Rapamycin, Cat. No. R-5000. |
|
SKF-104864A — see Topotecan, Hydrochloride Salt, Cat. No. T-9622. |
|
SKI-606 — see Bosutinib, Free Base, Cat. No. B-1709. |
|
SNDX-275 — see Entinostat, Free Base, Cat. No. E-3866. |
|
Solexa — see Celecoxib, Cat. No. C-1502. |
S-8599 |
Sorafenib, Free Base, >99% |
S-8502 |
Sorafenib, p-Toluenesulfonate Salt, >99% |
|
Sorafenib Tosylate — see Sorafenib, p-Toluenesulfonate Salt, Cat. No. S-8502. |
S-7979 |
SP600125, >99% |
|
Sprycel — see its active ingredient, namely Dasatinib, Free Base, Cat. No. D-3307. |
|
SR1 — see StemRegenin 1, Free Base, Cat. No. S-2440. |
|
SR-11247 — see Bexarotene, Free Acid, Cat. No. B-2422. |
S-9344 |
Stauprimide, >99% |
S-9300 |
Staurosporine, Free Base, >99% |
|
Staurosporine Aglycone — see K-252c, Cat. No. K-9609. |
|
Staurosporinone — see K-252c, Cat. No. K-9609. |
S-2440 |
StemRegenin 1, Free Base, >99% |
|
STI-571 — see Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508. |
|
SU-11248 — see Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877. |
|
Suberanilohydroxamic Acid — see Vorinostat, Cat. No. V-8477. |
|
Suberoylanilide Hydroxamic Acid — see Vorinostat, Cat. No. V-8477. |
S-8877 |
Sunitinib, Free Base, >99% |
|
Sunitinib Maleate — see Sunitinib, Malate Salt, Cat. No. S-8803. |
S-8803 |
Sunitinib, Malate Salt, >99% |
|
Sutent — see its active ingredient, namely Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877. |
|
Synergisidin — see Brefeldin A, Cat. No. B-8500. |
|
Tacedinaline — see CI-994, Free Base, Cat. No. C-2606. |
|
Tacrolimus — see FK-506, Cat. No. F-4900. |
|
TAK-165 — see Mubritinib, Free Base, Cat. No. M-5602. |
T-7802 |
Tandutinib, Free Base, >99% |
|
Tanespimycin — see 17-AAG, Cat. No. A-6880. |
|
Tarceva — see its active ingredient, namely Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007. |
|
Targretin — see its active ingredient, namely Bexarotene, Free Acid, Cat. No. B-2422. |
|
Targretyn — see Bexarotene, Free Acid, Cat. No. B-2422. |
|
Targrexin — see Bexarotene, Free Acid, Cat. No. B-2422. |
|
Tasigna — see its active ingredient, namely Nilotinib, Free Base, Cat. No. N-8207. |
|
Tasocitinib — see Tofacitinib, Free Base, Cat. No. T-1377. |
|
Taxol — see Paclitaxel, Cat. No. P-9600. |
|
Taxotere — see Docetaxel, Cat. No. D-1000. |
|
Telatinib — see 17-AAG, Cat. No. A-6880. |
T-8040 |
Temsirolimus, >99% |
|
12-O-Tetradecanoylphorbol 13-Acetate — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680. |
|
4α-12-O-Tetradecanoylphorbol 13-Acetate — see 4α-Phorbol 12-Myristate 13-Acetate, Cat. No. P-8880. |
T-3250 |
Thapsigargin, >99% |
|
Tifolar — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177. |
T-5096 |
Tinyatoxin, >99% |
T-9104 |
Tipifarnib, Free Base, >99% |
T-6466 |
Tivozanib, Free Base, 99% |
|
TKI-258 — see Dovitinib, Free Base, Cat. No. D-3608 and Dovitinib, Lactate Salt, Cat. No. D-3699. |
|
TNX — see Tinyatoxin, Cat. No. T-5096. |
T-1377 |
Tofacitinib, Free Base, >99% |
|
Tomtovok — see its active ingredient, namely Afatinib, Free Base, Cat. No. A-8644. |
|
Toposar — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
T-9622 |
Topotecan, Hydrochloride Salt, >99% |
|
Topotecin — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. |
|
Torisel — see its active ingredient, namely Temsirolimus, Cat. No. T-8040. |
|
Torkinib — see PP242, Free Base, Cat. No. P-6666. |
|
Tovok — see its active ingredient, namely Afatinib, Free Base, Cat. No. A-8644. |
T-2304 |
Tozasertib, Free Base, 99% |
|
TPA — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680. |
|
4α-TPA — see 4α-Phorbol 12-Myristate 13-Acetate, Cat. No. P-8880. |
|
Transplatin — see Oxaliplatin, Cat. No. O-7111. |
|
4',5,7-Trihydroxyisoflavone — see Genistein, Cat. No. G-6055. |
|
Tykerb — see its active ingredient, namely Lapatinib, Free Base, Cat. No. L-4899 and Lapatinib, Di-p-Toluenesulfonate Salt, Cat. No. L-4804. |
T-9142 |
Tyrphostin AG 490, >99% |
T-7310 |
Tyrphostin AG 1478, Free Base, >99% |
|
Tyrphostin B42 — see Tyrphostin AG 490, Cat. No. T-9142. |
|
Tyverb — see its active ingredient, namely Lapatinib, Free Base, Cat. No. L-4899 and Lapatinib, Di-p-Toluenesulfonate Salt, Cat. No. L-4804. |
|
TYX — see Tinyatoxin, Cat. No. T-5096. |
U-6770 |
U0126, >99% |
|
U-29135 — see Geldanamycin, Cat. No. G-4500. |
|
U-101440E — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. |
V-9402 |
Vandetanib, Free Base, >99% |
V-9077 |
Vargatef, Free Base, >99% |
V-8303 |
Vatalanib, Dihydrochloride Salt, >99% |
V-8355 |
Vatalanib, Free Base, >99% |
|
Velcade — see Bortezomib, Free Base, Cat. No. B-1408. |
V-2800 |
Vemurafenib, Free Base, >99% |
|
Vepesid — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
|
VER-52296 — see NVP-AUY922, Free Base, Cat. No. N-5300. |
V-8766 |
Vinorelbine, Ditartrate Salt, >99% |
V-8799 |
Vinorelbine, Free Base, >98% |
V-4050 |
Vismodegib, Free Base, >99% |
V-8477 |
Vorinostat, >99% |
|
VP-16 — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
|
VP-16-213 — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
|
VX6 — see Tozasertib, Free Base, Cat. No. T-2304. |
|
VX-680 — see Tozasertib, Free Base, Cat. No. T-2304. |
V-9366 |
VX-702, Free Base, >99% |
W-2990 |
Wortmannin, >99% |
|
Xabine — see Capecitabine, Cat. No. C-2799. |
|
Xalkori — see its active ingredient, namely Crizotinib, Free Base, Cat. No. C-7900. |
|
Xeloda — see its active ingredient, namely Capecitabine, Cat. No. C-2799. |
|
YM155 — see Sepantronium Bromide, Cat. No. S-7272. |
|
YM-177 — see Celecoxib, Cat. No. C-1502. |
|
Zactima — see Vandetanib, Free Base, Cat. No. V-9402. |
|
Zarnestra — see its active ingredient, namely Tipifarnib, Free Base, Cat. No. T-9104. |
|
ZD-1839 — see Gefitinib, Free Base, Cat. No. G-4408. |
|
ZD6474 — see Vandetanib, Free Base, Cat. No. V-9402. |
|
Zelboraf — see its active ingredient, namely Vemurafenib, Free Base, Cat. No. V-2800. |
|
ZK222584 — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355. |
|
ZK-62711 — see (R,S)-Rolipram, Cat. No. R-2020. |
|
Zolinza — see its active ingredient, namely Vorinostat, Cat. No. V-8477. |
|
Zortress — see its active ingredient, namely Everolimus, Cat. No. E-4040. |
Z-9040 |
Zotarolimus, >98% |
|
Zuyeyidal — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. |
Z-1066 |
ZSTK474, Free Base, >99% |
